Accelr8 Technology Corporation to Present at the Healthcare Robins Roadshow.Business Editors Robins Roadshow Healthcare Equity Conference DENVER--(BUSINESS WIRE)--June 7, 2004 Accelr8 Technology Corporation (AMEX AMEX See: American Stock Exchange :AXK), will be presenting at the Robins Roadshow Healthcare Equity Conference June 10, 2004, at 8:00 a.m. Eastern Time This conference presentation is being webcast by Thomson/CCBN and can be accessed at the following URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. address: www.robinsmediagroup.com/healthcare The webcast is also being distributed over Thomson/CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson/CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson/CCBN's Individual Investor Network. Institutional investors can access the call via Thomson/CCBN's password-protected event management site, StreetEvents (www.streetevents.com). Accelr8 Technology Corporation (www.accelr8.com) owns patented technology that provides exceptional speed and sensitivity in assay performance for rapid medical diagnostics. A key material is its surface chemistry, OptiChem(TM), which has a unique ability to block interference from sticky substances in blood and other biological specimens. The company takes advantage of this noise-reduction by using it as a coating for assay "biochips" for its own products as well as licensees. The company's patented instrumentation takes advantage of this novel biochip biochip Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of capability as featured in its new developmental diagnostic platform, BACcelr8r(TM) which consists of an instrumentation system and disposable biochips. The company's scientists believe that the BACcelr8r will provide specific diagnostic and drug susceptibility (antibiotic resistance antibiotic resistance, n the ability of certain strains of microorganisms to develop resistance to antibiotics. antibiotic resistance ) data in less than 8 hours rather than the current 2 to 3 days with conventional bacterial analyses. If successful, this innovative system will enable physicians to select effective antibiotics within the narrow time window required to successfully treat life-threatening infections, such as VAP (Value Added Process) An executable program in a NetWare 2.x server. Starting with NetWare 3.x, VAPs were replaced by NLMs. See NetWare. (ventilator associated pneumonia). The conference will be moderated by Marc Robins, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , the founder of Catalyst Financial Resources and founder of The Red Chip Review. Marc has 25 years of experience in capital markets. Experience which includes a regularly featured column in Forbes, contributed articles in the AAII AAII See: American Association of Individual Investors Journal and his frequent quotes found in various financial media. The conference is part of a series of Robins Roadshows provided by Robins Media Group and Catalyst Financial Resources. These Roadshows place small-cap companies before a professional audience of buy-side, sell-side analysts, portfolio managers, research directors, and chief investment officers whose investment styles are relative to the profiles of the presenting companies. Also appearing and delivering the keynote address keynote address n. An opening address, as at a political convention, that outlines the issues to be considered. Also called keynote speech. Noun 1. will be Blair Childs, Executive Vice President of Strategic Planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. and Implementation for AdvaMed. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion